These findings offer new, such as biomarkers Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-6 (IL-6), for the early diagnosis and intervention strategies of trauma-induced coagulopathy, providing a theoretical basis and practical guidance for future clinical applications. This evidence concerns the gene IL6 and blood coagulation disease.